Study: The outbreak in Aumicron in the UK has peaked

UK research shows that covid-19 in Omiquerong has peaked in the UK, with cases beginning to decrease across all age groups and in almost all parts of the country.

On Jan. 13, Tim Spector, professor of genetic epidemiology at King's College London and chief scientist at the ZOE COVID-19 Symptom Study APP, said the data suggested the UK's Wave of Omilon had peaked, with hospitalisations, deaths and early data on the severity of Omilon "looking optimistic".

For the first time this winter, he said, COVID-19 infections are "more common than colds and flu, and symptoms between the two are difficult to distinguish."

According to data from the ZOE study, 52.5 percent of people with new cold-like symptoms are likely to be infected with COVID-19, up from 51.3 percent last week.

The UK currently has an average of 183364 new cases per day, a significant 12% drop from 208471 reported last week.

Among those who received at least two doses of the vaccine, there are currently 83,699 new cases per day, an 11 percent decrease from the 93,540 cases reported last week.

The study found that cases are declining in all parts of the country except the northeast, and even in the northeast, the rate of growth in cases has slowed and should soon begin to decline.

Daily new cases are also declining across all age groups, with cases in people over 75 years of age stable at low levels.

Spector said it was a "reassuring sign" that more vulnerable groups had survived the worst wave of Omikeron.

He said he doesn't think the rates will drop to zero, but he thinks Omiljung "will most likely continue to spread through the population at controlled levels until late spring." ”

Some scientists have predicted that in the UK, COVID-19 will soon become endemic.

Professor David Heymann of the London School of Hygiene and Tropical Medicine said on 11 January that herd immunity in the UK is high and could be "the closest country to emerge from an outbreak" (from the perspective of treating it as an endemic disease).

Clive Dix, former chairman of the UK Vaccine Task Force, said over the weekend that mass COVID-19 vaccinations should be stopped and that the UK should manage COVID-19 as an endemic disease such as influenza.

Earlier, Paul Hunter, a professor of medicine at the University of East Anglia in the United Kingdom, also said on December 28 that the new crown will become "a common cold".